Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: Journal of Medical Internet Research

Date Submitted: Jan 10, 2026
Open Peer Review Period: Jan 12, 2026 - Mar 9, 2026
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Efficacy of Virtual Agent-Based Digital Intervention (Echo-App V2.0) for Patients with Alcohol Use Disorder: A Randomized Controlled Trial

  • Shuo Li; 
  • Weicong Sang; 
  • Dapeng Zhang; 
  • Ruihua Li; 
  • Wei Yuan; 
  • Jingyang Liu; 
  • Huixue Li; 
  • Meimei Liu; 
  • Yunchun Zhang; 
  • Bingqian Zhang; 
  • Qianying Wu; 
  • Chuanning Huang; 
  • Haidi Shan; 
  • Jiang Du; 
  • Haifeng Jiang; 
  • Na Zhong; 
  • Tianzhen Chen; 
  • Min Zhao

ABSTRACT

Background:

Traditional conversational agents have emerged as potential psychological tools in mental health field. While the text-only interactions limit compliance and efficacy. Virtual agents (VAs) show great potential to solve this problem.

Objective:

This study aimed to assess whether the combination of Echo appV2.0, a VA-based digital psychological intervention and TAU (Treatment as usual) yield greater efficacy compared to TAU alone.

Methods:

93 participants were randomized to 4-week Echo-app-v2.0 intervention combined with TAU compared to TAU alone. The primary outcome was change of craving. Secondary outcomes were relapse and change of emotional state, sleep quality, and treatment motivation.

Results:

The intervention group showed significant lower craving at week 8(β = -1.81, 95% CI: [-3.45, -0.16], p = 0.03) and week 16 (β = -1.97, 95% CI: [-3.61, -0.32], p = 0.02). A significant difference in relapse between the two groups at the week 8 follow-up (χ2=4.09, P=0.04). Statistically significant larger improvement in sleep quality was found in the intervention group (β = -3.28, 95% CI: [-5.08, -1.49], p <0.001). Perceived stress decreased significantly over time (β = -2.91, 95% CI: [-5.27, -0.56], p = 0.02). Linear regression showed that group and change in PSS significantly predicted Craving change at week 8(intervention: β = -2.13, 95% CI: [-4.03, -0.24], p = 0.03 ;PSS: β = 0.15, 95% CI: [0.03, 0.26],p = 0.02) and week 16(intervention:β= -2.24, 95% CI: [-4.07, -0.42], p = 0.02;PSS: p = 0.03).Both group (β = 0.12, 95% CI: [0.01, 0.24], p = 0.03) and abstinence frequency (β = 0.27, OR = 1.31, 95% CI: [1.06, 1.63], p = 0.01) significantly predict relapse at week 8.

Conclusions:

Echo app V2.0 has certain therapeutic potential in treating AUD, but further adjustments to the intervention are needed to enhance its long-term efficacy. Clinical Trial: ClinicalTrials.gov Identifier: NCT05675553


 Citation

Please cite as:

Li S, Sang W, Zhang D, Li R, Yuan W, Liu J, Li H, Liu M, Zhang Y, Zhang B, Wu Q, Huang C, Shan H, Du J, Jiang H, Zhong N, Chen T, Zhao M

Efficacy of Virtual Agent-Based Digital Intervention (Echo-App V2.0) for Patients with Alcohol Use Disorder: A Randomized Controlled Trial

JMIR Preprints. 10/01/2026:91065

DOI: 10.2196/preprints.91065

URL: https://preprints.jmir.org/preprint/91065

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.